Evotec and Odyssey Therapeutics Enter AI-Enabled R&D Collaboration in Autoimmune and Inflammatory Diseases

Summary

Evotec and Odyssey Therapeutics announced an AI-enabled R&D collaboration combining Odyssey's disease biology expertise with Evotec's AI-enabled discovery platform and screening capabilities to advance Odyssey's discovery-stage autoimmune and inflammatory disease programs.